CMCR Symposium - October 18, 2019

The Center for Medicinal Cannabis Research (CMCR) hosted a one-day symposium celebrating the pioneers and exploring the progress, promise, and challenges of medicinal cannabis research.

During the symposium, two pioneers in medicinal cannabinoid research were honored:

Raphael Mechoulam, PhD
(Hebrew University) - Dr. Mechoulam has made groundbreaking discoveries in the field of cannabinoid chemistry since the 1960s. He coined the term “cannabinoid”. In 1964, Dr. Mechoulam’s laboratory first identified and synthesized delta-9-tetrahydrocannabinol (“THC”), the main psychoactive component of cannabis. Since then, his team has gone on to identify the structure of most of the cannabinoids and their metabolites and to discover the endogenous cannabinoids anandamide and 2-arachidonylglycerol (2-AG). An author of more than 300 publications, Dr. Mechoulam holds over 20 patents. Known for his scientific vision and warmth, we are pleased to honor his achievements and outstanding contribution to the field of medicinal cannabis with the Pioneer in Medicinal Cannabis Award.

Geoffrey Guy, MBBS (GW Pharmaceuticals) - Dr. Guy founded GW Pharmaceuticals and has served as its Chairman since 1998. Dr. Guy created Epidiolex, the first formulation of cannabidiol to receive approval from the US Food and Drug Administration, and Sativex. He continues to lead innovation and new product discovery for cannabinoid-based medicine. He has been the physician in charge of over 300 clinical studies including pharmacokinetic, pharmacodynamic, and dose-ranging studies, controlled clinical trials, and large scale multi-centered studies and clinical surveys. An innovator in medical research and global drug development for his entire career, the CMCR is pleased to honor his achievements and outstanding contribution to the field of medicinal cannabis with the CMCR Award for Advancing Cannabis and Cannabinoids as Therapeutics.

 SYMPOSIUM AGENDA - Friday, October 18, 2019


8:00 AM


Igor Grant, MD, CMCR Director, UC San Diego

8:15 AM

Pioneer in Medicinal Cannabis Research Award

Raphael Mechoulam, PhD, Hebrew University of Jerusalem

8:50 AM




Advancing Cannabis and Cannabinoids as Therapeutics Award

Presentation on Cannabinoid Therapeutics: Harnessing the medicinal properties of cannabis: from plant to medicine

Geoffrey Guy, MBBS, GW Pharmaceuticals




9:20 AM Discussion/Future Directions  
SESSION 1 The Anti-Inflammatory Properties of Cannabinoids  
9:35 AM Transdermal cannabidiol in animal model of arthritis

Karin Westlund-High, PhD, University of New Mexico

9:50 AM The immunomodulary effect of cannabis use in HIV Jennifer Manuzak, PhD, University of Miami Miller School of Medicine
10:05 AM Discussion/Future Directions  
10:15 AM BREAK  
SESSION 2 The Promise of Cannabidiol  
10:30 AM Cannabidiol and receptor physiology Fabricio Moreira, PhD, Universidade Federal de Minas Gerais, Brazil
10:45 AM Cannabidiol ameliorates the memory-impairing effects of THC in non-human primates Michael Taffe, PhD, UC San Diego
11:00 AM Cannabidiol in reducing nicotine dependence Olivier George, PhD, UC San Diego
11:15 AM Discussion/Future Directions  
SESSION 3 The Potential Opioid Sparing Effects of Cannabinoids  
11:30 AM The endocannabinoid system and pain Aron Lichtman, PhD, Virginia Commonwealth University
11:45 AM Human lab experiments of cannabinoids and pain Ziva Cooper, PhD, UCLA
NOON Does cannabis moderate opioid use in chronic pain? Michelle Sexton, ND, UC San Diego
12:15 PM Discussion/Future Directions  
SESSION 4 Safeguarding, Educating, and Learning from Cannabis use in the Public Sphere  
1:30 PM Recent findings on the effects of medicinal and recreational cannabis laws on youth consumption Denise Walker, PhD, University of Washington
1:45 PM Impact and detection of cannabis impaired driving Thomas Marcotte, PhD, UC San Diego
2:00 PM What are the promises and limitations of various cannabinoid testing platforms Robert Fitzgerald, PhD, UC San Diego
2:15 PM Discussion/Future Directions  
SESSION 5 Panel Discussion - State of California Approach Discussants
2:30 PM   Lori Ajax, Chief, California Bureau of Cannabis Control
    Tom Lackey, California Assemblyman District 36
3:15 PM BREAK  
SESSION 6 Achieving Priorities in Medicinal Cannabis Research  
3:30 PM Introduction Igor Grant, MD, CMCR Director, UC San Diego
  Public-private partnerships to advance cannabis and cannabinoid based medicines
Gail Taylor, BSc, PhD, FSB, UC Davis and University of Southampton
3:50 PM Legislative and Regulatory Issues  
  Update from HHS: Supply and Regulatory Issues Steve Gust, PhD, NIDA
  Issues in receiving an IND for human cannabinoid studies Dominic Chiapperino, PhD, FDA
  Legislative initiatives to facilitate medicinal cannabinoid research

Trelaine Ito, Office of US Senator Brian Schatz

 4:20 PM Panel Discussion: Perspectives and opportunities from industry and philanthropy  Discussants
    Alice Mead, JD, GW Pharmaceuticals
    Pelin Thorogood, Wholistic Research and Education Foundation
    George Hodgin, Biopharmaceutical Research Company
    Hunter Land, Canopy Growth
    Dennis Kim, MD, MBA, Emerald Bioscience
5:15 PM Closing Remarks Igor Grant, MD, CMCR Director, UC San Diego



Location:  UC San Diego's Atkinson Hall, San Diego, California

About the CMCR

This email address is being protected from spambots. You need JavaScript enabled to view it.



Estancia La Jolla Hotel & Spa

9700 N Torrey Pines Road, La Jolla, CA 92037; Telephone: (858) 550-1000

Hyatt Regency La Jolla at Aventine

3777 La Jolla Village Drive, San Dieog, CA 92122; Telephone: (858) 552-1234

Hotel La Jolla, Curio Collection by Hilton

7955 La Jolla Shores Drive, La Jolla, CA 92037; Telephone: (858) 551-3600


Copyright © 2019 CENTER FOR MEDICINAL CANNABIS RESEARCH. | University of California, San Diego | HNRP |